Naturally occurring and experimentally induced β-amyloid deposits in the brains of marmosets (Callithrix jacchus)

Journal of Neural Transmission

Volumn 107, Issue 7, 2000, Pages 799-814

  Maclean, C J ^a   Baker, H F ^a   Ridley, R M ^a   Mori, H ^b  

^a Department Experimental Psychology   (United Kingdom)

^b OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Aging; Alzheimer's disease; Amyloid; Cerebrovascular amyloid; Marmoset; Non human primate; Senile plaques

Indexed keywords

AMYLOID BETA PROTEIN;

AGE; ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN HOMOGENATE; CONTROLLED STUDY; FEMALE; MALE; MARMOSET; NONHUMAN; PRIORITY JOURNAL; TIME;

AGE FACTORS; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; ANIMALS; BRAIN; BRAIN CHEMISTRY; CALLITHRIX; CEREBRAL AMYLOID ANGIOPATHY; FEMALE; MALE;

EID: 0033925990     PISSN: 03009564     EISSN: None     Source Type: Journal    
DOI: 10.1007/s007020070060     Document Type: Article

References (25)

1. 43 (Aβ42). Neurochem Res 22: 1499-1505
2. Baker HF, Ridley RM, Crow TJ, Bloxham CA, Parry RP, Tyrrell DA (1983) An investigation of the effects of intracerebral injection in the marmoset of cytopathic cerebrospinal fluid from patients with schizophrenia or neurological disease. Psychol Med 13: 499-511
3. Baker HF, Ridley RM, Crow TJ, Tyrell DA (1989) A re-investigation of the behavioural effects of intracerebral injection in marmosets of cytopathic cerebrospinal fluid from patients with schizophrenia or neurological disease. Psychol Med 19: 325-329
4. Baker HF, Ridley RM, Duchen LW, Crow TJ, Bruton CJ (1993) Evidence for the experimental transmission of cerebral β-amyloidosis to primates. Int J Exp Pathol 74: 441-453
5. Baker HF, Ridley RM, Duchen LW, Crow TJ, Bruton CJ (1994) Induction of β-amyloid in primates by injection of Alzheimer's disease brain homogenate: comparison with transmission of spongiform encephalopathy. Mol Neurobiol 8: 25-40
6. 40: evidence from cats and dogs. Neurobiol Aging 17: 653-659
7. Dayan AD (1971) Comparative neuropathology of ageing. Brain 94: 31-42
8. Ferrier IN, Cross AJ, Johnson JA, Roberts GW, Crow TJ, Corsellis JA, Lee YC, O'Shaughnessy D, Adrian THE, McGregor GP, Polak JM, Bloom SR (1983) Neuropeptides in Alzheimer type dementia. J Neurol Sci 62: 159-170
9. 40 is a major form of β-amyloid in nonhuman primates. Neurobiol Aging 17: 903-908
10. Gearing M, Tigges J, Mori H, Mirra SS (1997) β-amyloid (Aβ) deposition in the brains of aged orangutans. Neurobiol Aging 18: 139-146
11. Geula C, Wu C-K, Saroff D, Lorenzo A, Yuan M, Yankner BA (1998) Aging renders the brain vulnerable to amyloid β-protein neurotoxicity. Nature Med 4: 827-831
12. Ghetti B, Murrell J, Benson MD, Farlow MR (1992) Spectrum of amyloid beta-protein immunoreactivity in hereditary Alzheimer disease with a guanine to thymine missense change at position 1924 of the APP gene. Brain Res 571: 133-139
13. Honavar M, Lantos PL (1987) Ultrastructural changes in the frontal cortex and hippocampus in the ageing marmoset. Mech Ageing Dev 41: 161-175
14. Hsiao K, Baker HF, Crow TJ, Poulter M, Owen F, Terwilliger JD, Westaway D, Ott J, Prusiner SB (1989) Linkage of a prion protein missense variant to Gerstmann-Straussler syndrome. Nature 338: 342-345
15. Mann DM, Iwatsubo T, Nochlin D, Sumi SM, Levy LE, Bird TD (1997) Amyloid (Abeta) deposition in chromosome 1-linked Alzheimer's disease: the Volga German families. Ann Neurol 41: 52-57
16. Mann DM, Iwatsubo T, Pickering BS, Owen F, Saido TC, Perry RH (1997) Preferential deposition of amyloid beta protein (Abeta) in the form Abeta40 in Alzheimer's disease is associated with a gene dosage effect of the apolipoprotein E E4 allele. Neurosci Lett 221: 81-84
17. Masters CL, Gajdusek DC, Gibbs CJ (1981) Creutzfeldt-Jakob disease virus isolations from the Gerstmann-Sträussler syndrome. Brain 104: 559-588
18. Murrell J, Farlow M, Ghetti B, Benson MD (1991) A mutation in the amyloid precursor protein associated with hereditary Alzheimer's disease. Science 254: 97-99
19. Nakamura S, Tamaoka A, Sawamura N, Shoji S, Nakayama H, Ono F, Sakakibara I, Yoshikawa Y, Mori H, Goto N, Doi K (1995) Carboxyl end-specific monoclonal antibodies to amyloid beta protein (A beta) subtypes (A beta 40 and A beta 42(43)) differentiate A beta in senile plaques and amyloid angiopathy in brains of aged cynomolgus monkeys. Neurosci Lett 201: 151-154
20. Sawamura N, Tamaoka A, Shoji S, Koo EH, Walker LC, Mori H (1997) Characterization of amyloid β protein species in cerebral amyloid angiopathy of a squirrel monkey by immunocytochemistry and enzyme-linked immunosorbent assay. Brain Res 764: 225-229
21. Selkoe DJ, Bell DS, Podlisny MB, Price DL, Cork LC (1987) Conservation of brain amyloid proteins in aged mammals and humans with Alzheimer's disease. Science 235: 873-877
22. Stephan H, Baron G, Schwerdtfeger WK (1980) The brain of the common marmoset (Callithrix jacchus): a stereotaxic atlas. Springer, Berlin Heidelberg New York
23. Struble RG, Price DL Jr, Cork LC, Price DL (1985) Senile plaques in cortex of aged normal monkeys. Brain Res 361: 267-275
24. von Braunmühl AV (1956) 'Kongophile Angiopathie' und 'senile plaques' bei greisen Hunden. Arch Psychiat Z Neurol 194: 396-414
25. Walker LC (1997) Animal models of cerebral β-amyloid angiopathy. Brain Res Rev 25: 70-84